Logo

People in the News: Bruker, InterWest Partners

Jan 12, 2013
Premium

Bruker said this week it has appointed Joshua Young vice president of investor relations. Young will take over from Stacey Desrochers, who will focus on management of the company's treasury operations.

Previously Young was global head of investor relations at Merck KGaA. Before that he was head of investor relations at Millipore.

Venture capital firm InterWest Partners announced this week that Doug Fisher has been promoted to partner.

Fisher joined InterWest as a principal in 2009 and since then has been involved in InterWest investments in a variety of biotech firms including proteomic diagnostic companies Sera Prognostics and Integrated Diagnostics.

Filed under

Proteomics & Protein Research
proteomics
Bruker
InterWest Partners
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.